What is Regenxbio's change in deferred revenue?

Regenxbio (RGNX) reported change in deferred revenue of -$700K in Q1 2026.

How has Regenxbio's change in deferred revenue changed year-over-year?

Regenxbio's change in deferred revenue decreased by 101.8% year-over-year, from $39.77M to -$700K.

What does change in deferred revenue mean?

Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.

Regenxbio RGNX Change in Deferred Revenue

Change in Deferred Revenue at other companies

Regeneron PharmaceuticalsREGN

$99.6M+463%

Sarepta Therapeutics, Inc.SRPT

-$274.92M-222%

EyePoint, Inc. EYPT

$0+100%

Ultragenyx PharmaceuticalRARE

$0+100%

4D Molecular TherapeuticsFDMT

$1.38M+9,957%

PrecigenPGEN

-$107K+22.5%

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredRevenue.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's change in deferred revenue?: Regenxbio (RGNX) reported change in deferred revenue of -$700K in Q1 2026.
How has Regenxbio's change in deferred revenue changed year-over-year?: Regenxbio's change in deferred revenue decreased by 101.8% year-over-year, from $39.77M to -$700K.
What does change in deferred revenue mean?: Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.